To content
.
Investor Portal
Menu
Home
Team
Fund 3
News
Fund 3
Sustainability-related
disclosures
Contact
.
News
Vesalius News
07/25/2025
Memo Therapeutics: Phase II Trial Results
read more
06/20/2025
Memo Therapeutics on WTC 2025
read more
06/11/2025
Memo Therapeutics: Study Transcytosis
read more
.
xxnoxx_zaehler